Loading
Latest filing published 05 Jun 2026 for XSpray Pharma AB (publ), €45k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Anders Lennart Bladh, Ribbskottet (board member) discloses dealings in XSpray Pharma AB (publ) to Finansinspektionen. The record holds 6 filings, for trades running from 9 September 2025 to 3 June 2026.
No open-market sale appears; the market trades are 2 purchases worth €90k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 2 purchases and no sales.
The newest entry dates from 5 June 2026: an open-market purchase of €45k, in XSpray Pharma AB (publ). Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations